Oxidative Stress and Related Consequences in Patients with Type 2 Diabetic Mellitus
DOI:
https://doi.org/10.63682/jns.v14i32S.8221Keywords:
Diabetic, T2D, Complications, Oxidative stress, TACAbstract
Background: An imbalance between biochemical pathways that increase ROS generation and the body's antioxidant defense system causes oxidative stress (OS), a metabolic disorder. It's linked to heart disease, cancer, neurological issues, aging, and respiratory infections.
Objective: This study compared persons with and without complications from type 2 diabetes (T2D) in terms of their total antioxidant capacity and total oxidative stress in the blood.
Methods: The sample consisted of 80 T2D patients, either with or without subsequent complications. Two groups of participants were formed: those with diabetes (Diab) and those with secondary complications (DSC). To extract serum, blood samples were taken. The colorimetric approach was used to assess the serum samples' total antioxidant capacity (TAC) and total oxidative stress (TOS).SPSS 23.0 was used to analyze all data.
Results: Blood glucose and total oxidative stress were considerably (p=0.05) greater in the Diab group than in the DSC group. However, the DSC group's total antioxidant capacity was considerably (p<0.003) lower than the Diab group.Patients with T2D who experienced secondary problems had higher levels of oxidative stress.
Conclusion: The conclusion showed that total oxidative stress was higher and total antioxidant capacity was lower in type 2 diabetic patients compared to non-diabetic individuals; this, in turn, causes the development of difficulties related to the disease
Downloads
References
Roser M, Ritchie H, Spooner F. Burden of disease. Our World Data (2021). Available at: https://ourworldindata.org/burden-of-disease.
Safiri S, Karamzad N, Kaufman JS, Bell AW, Nejadghaderi SA, Sullman MJM, et al. Prevalence, deaths and disability-Adjusted-Life-Years (DALYs) due to type 2 diabetes and its attributable risk factors in 204 countries and territories, 1990-2019: results from the global burden of disease study 2019. Front Endocrinol (2022) 13:1–14. doi: 10.3389/fendo.2022.838027
Echouffo-Tcheugui JB, Selvin E. Prediabetes and what it means: the epidemiological evidence. Annu Rev Public Health (2020) 42:59–77. doi: 10.1146/annurev-publhealth-090419-102644
Korac B, Kalezic A, Pekovic-Vaughan V, Korac A, Jankovic A. Redox changes in obesity, metabolic syndrome, and diabetes. Redox Biol (2021) 42. doi: 10.1016/j.redox.2021.101887
Bigagli E, Lodovici M. Circulating oxidative stress biomarkers in clinical studies on type 2 diabetes and its complications. Oxid Med Cell Longev (2019) 2019. doi: 10.1155/2019/5953685
Yaribeygi H, Sathyapalan T, Atkin SL, Sahebkar A. Molecular mechanisms linking oxidative stress and diabetes mellitus. Oxid Med Cell Longev (2020) 2020. doi: 10.1155/2020/8609213
Vlassara, H. Recent progress in advanced glycation end products and diabetic complications. Diabetes 1997, 46 (Suppl. S2), S19–S25
Koya, D.; King, G.L. Protein kinase C activation and the development of diabetic complications. Diabetes 1998, 47, 859–866
Pfeiffer, A.; Schatz, H. Diabetic microvascular complications and growth factors. Exp. Clin. Endocrinol. Diabetes 1995, 103, 7–14.
Nishikawa, T.; Edelstein, D.; Brownlee, M. The missing link: A single unifying mechanism for diabetic complications. Kidney Int. Suppl. 2000, 77, S26–S30.
Dabravolski SA, Nikiforov NG, Starodubova AV, Popkova TV, Orekhov AN. The role of mitochondria-derived peptides in cardiovascular diseases and their potential as therapeutic targets. Int J Mol Sci (2021) 22(16). doi: 10.3390/ijms22168770
Jelinek HF, Helf C, Khalaf K. Human SHC-transforming protein 1 and its isoforms p66shc: a novel marker for prediabetes. J Diabetes Investig (2021) 12(10):1881–1889 doi: 10.1111/jdi.13551
Moussa SA. 2008. Oxidative stress in Diabetes Mellitus, Romanian Journal of Biophysics 18(3), p 225-236. http://dx.doi.org/10.1.1.326.6470&rep=rep1&type=p df.
Evans JL, Goldfine ID, Maddux BA, Grodsky GM. 2003. Are oxidative stress-activated signaling pathways mediators of insulin resistance and b-cell dysfunction? Diabetes 52, 1-8. http://dx.doi.org/10.2337/diabetes.52.1.1.
Farasat T, Cheema AM, Khan MN. 2009. Correlation Among BMI, Fasting Plasma Glucose and HbA 1c Levels in Subjects with Glycemic Anomalies Visiting Diabetic Clinics of Lahore Pakistan Journal of Zoology 41(3), p 173-178. http://dx.doi.org/0030-9923/2009/0003-0173
Fawwad A, Qasim R, Hydrie ZI, Basit A, Miyan Z, Gul A. 2006. Correlation of fasting insulin resistance indices with clinical parameters of metabolic syndrome in type 2 diabetic subjects. Pakistan Journal of medical. Sciences 2. http://dx.doi.org/433.53e61ff30cf2fb7487185a5c.
Varadharaj S, Kelly OJ, Khayat RN, Kumar PS, Ahmed N, Zweier JL. 2017. Role of Dietary Antioxidants in the Preservation of Vascular Function and the Modulation of Health and Disease. Frontiers in cardiovascular medicine 4. https://doi.org/10.3389/fcvm.2017.00064.
Zargari M, Arab H, Ghafouri Z. 2018. Evaluation of the Salivary Total Antioxidant Capacity and Lipid Peroxidation Status in Type 2 Diabetes Mellitus Patients: Iranian Journal of Diabetes and Obesity, Volume 10, Number 2. https://www.researchgate.net/publication/32827515 9.
Verma S, Sagar N, Vats P, Shukla K, Abbas M, Banerjee M. 2018. Antioxidant enzyme levels as markers for type 2 diabetes mellitus. International Journal of Bioassays 2(4), 685 -90. https://www.researchgat.net/publication/261510559.
Savu O, Tirgoviste CI, Atanasiu V, Gaman L, Papacocea R, Stoian I. 2012. Increase in Total Antioxidant Capacity of Plasma Despite High Levels of Oxidative Stress in Uncomplicated Type 2 Diabetes Mellitus; the Journal of International Medical Research 40, 709 716. http://dx.doi.org/10.1177/14733230011240
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
